Diagnosis of CAD S Richard Underwood

Similar documents
The NICE chest pain guideline 1 year on. Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust

How to investigate (Cardiac) Chest Pain

CHRONIC CAD DIAGNOSIS

Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

FFR-CT Not Ready for Primetime

Current and Future Imaging Trends in Risk Stratification for CAD

P F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia

My Patient Needs a Stress Test

Pearls & Pitfalls in nuclear cardiology

Coronary Heart Disease. Iqbal Malik

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Atypical pain and normal exercise test

Patient-centered Imaging in Coronary Artery Disease. Jason H Cole, MD, MS, FACC January 10, 2015

New Stable Chest Pain Guidance in the UK NICE to have, difficult to implement

Long-term outcome after normal myocardial perfusion imaging in suspected ischaemic heart disease

Chest Pain in Women ;What is Your Diagnostic Plan? No Need for Noninvasive Test

Welcome! To submit questions during the presentation: or Text:

Chest pain of recent onset: assessment and diagnosis

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

Clinical guideline Published: 24 March 2010 nice.org.uk/guidance/cg95

Stable Angina: Indication for revascularization and best medical therapy

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice

PET myocard perfusion & viability Riemer Slart

Cardiogenic Shock. Carlos Cafri,, MD

I have no financial disclosures

Chest Pain Wave I. Making Dollars and Sense Out of Stress Testing

Καηεσθσνηήριες οδηγίες για ηην εκηίμηζη και ηη διάγνωζη ηης ζηαθερής ζηηθάγτης

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

Test in Subjects with Suspected CAD Anatomic Study is Better

Disclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview

Maria Angela S. Cruz-Anacleto, MD

Stress Testing:Which Study is Indicated for My Patient?

Diagnostic and Prognostic Value of Coronary Ca Score

Nuclear Perfusion Imaging of Angina

Imaging in Ischemic Heart Disease: Role of Cardiac MRI

Rapid access chest pain clinic (RACPC)

Evidence for Everyone: Expanding the Reach of Health Technology Assessment 2016 CADTH Symposium, April 10-12, Shaw Centre, Ottawa

Appropriateness of Stress Echocardiography and Nuclear Stress Thallium/Sesta Mibi Testing Methods

Chest pain management. Ruvin Gabriel and Niels van Pelt August 2011

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease?

CASE from South Korea

Multisclice CT in combination with functional imaging for CAD. Temporal Resolution. Spatial Resolution. Temporal resolution = ½ of the rotation time

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

21st Annual Contemporary Therapeutic Issues in Cardiovascular Disease

Patient referral for elective coronary angiography: challenging the current strategy

Advanced Imaging MRI and CTA

The Role of Computed Tomography in the Diagnosis of Coronary Atherosclerosis

The 2016 NASCI Keynote: Trends in Utilization of Cardiac Imaging: The Coronary CTA Conundrum. David C. Levin, M.D.

Diagnostic Algorithms

Role of Myocardial Perfusion Imaging in the Cardiac Evaluation of Aviators

Malaysian Healthy Ageing Society

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Technical Meeting on: Current Role of Nuclear Cardiology in the Management of Cardiac Diseases Vienna, May 2008 Vienna International Centre

Coronary interventions

HEART CONDITIONS IN SPORT

msv Stress dose (mci) Stress dose (MBq)

Exercise Test: Practice and Interpretation. Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine

Myocardial Perfusion SPECT How to do it E. Moralidis

Calcium scoring Clinical and prognostic value

Diagnostic and prognostic benefits of CTCA using the 2016 NICE guidance within a randomised trial

Non Invasive Diagnostic Modalities for Coronary Artery Disease. Dr. Amitesh Aggarwal

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina

Bayes Theorem and diagnostic tests with application to patients with suspected angina

SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin

Noninvasive Evaluation of Coronary Artery Disease:

Is computed tomography angiography really useful in. of coronary artery disease?

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

NUCLEAR CARDIOLOGY UPDATE

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Authors: Ozan M Demir, A Peter Dobson, B Nikolaos D Papamichael, C Jonathan Byrne, D Sven Plein E and Khaled Alfakih F ABSTRACT.

Ischaemic Heart Disease

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

MD F A F C A C MAS A N S C

Cardiovascular Disease

High Value Evaluation of Chest Pain. Zoom Tips

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

Coronary Revascularization for Severe LV Dysfunction Is s. Is the concept of viability testing still viable?

CT or PET/CT for coronary artery disease

Management of stable CAD FFR guided therapy: the new gold standard

Clinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126

Ischaemic heart disease. IInd Chair and Clinic of Cardiology

Cardiac Conditions in Sport & Exercise. Cardiac Conditions in Sport. USA - Sudden Cardiac Death (SCD) Dr Anita Green. Sudden Cardiac Death

2/17/2010. Grace Lin, MD Assistant Professor of Medicine University of California, San Francisco

New Challenges in Nuclear Cardiology Practice

Risk Stratification for CAD for the Primary Care Provider

Stress only Perfusion Imaging

Reducing the Population Health Burden of Cardiovascular Disease

DIAGNOSTIC TESTING IN PATIENTS WITH STABLE CHEST PAIN

Evaluating Clinical Risk and Guiding management with SPECT Imaging

The Role of Nuclear Imaging in Heart Failure

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

CARDIAC MULTIMODALITY IMAGING: Informing better decisions - or just costly pictures?

ORIGINAL ARTICLE. Iulia Heinle 1,*, Andre Conradie 2 and Frank Heinle 1

Case-Based Pitfalls of SPECT and PET: Recognizing and Working with Artifacts

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging. ID: GOLD Date: Age: 46 Sex: M John Doe Phone (310)

Coronary Revascularization in Patients witj Severe LV Dysfunction.: Is the concept of viability still viable?

Transcription:

Diagnosis of CAD S Richard Underwood Professor of Cardiac Imaging Royal Brompton Hospital & Imperial College Faculty of Medicine London, UK

The history and diagnosis 89% Non-cardiac chest pain 50% Atypical angina Typical angina 16% Diamond & Forrester NEJM 1979;300:1350 Percent coronary disease

Pre-test likelihood of CAD Score Probability of CAD Age line Score Angina typical 26 atypical 10 non-cardiac 0 MI history 11 Q waves 12 both 30 ECG ST/T changes 6 70 60 50 40 30 20 10 99 90 80 70 60 50 40 30 20 10 01 80 70 60 50 40 30 20 80 80 80 70 70 70 60 60 60 50 50 50 40 30 40 40 20 30 30 20 20 Both Smoker Lipids Diabetes 7 0 No smoker or lipids Prior DB, et el. Am J Med 1983; 75: 771-780

Myocardial perfusion The ischaemic cascade hypoperfusion metabolic alterations diastolic dysfunction systolic dysfunction ECG-Changes angina Signs of ischaemia

Inducible Perfusion Abnormality Stress Rest

Detection of CAD Sensitivity Specificity Ex-ECG 1 0.68 0.77 MPI 2 0.91 0.89 1 Gianrossi R, et al. Circulation 1989; 80: 87-98 147 studies, 24074 patients 2 Maddahi J. Cardiac Imaging, edition 2. WB Saunders 1996: 971-994 9 studies, 2396 patients, qualitative and quantitative SPECT

Sensitivity Specificity MPS for Detection of CAD 100% 90% 80% 70% 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 1988 1990 1992 1994 1996 1998 2000 60% 50% 40% 30% 20% 10% 0% 1988 1990 1992 1994 1996 1998 2000 Miller DD, Shaw LJ. J Nucl Cardiol 2001; 8: 616-9

Diagnosis of CAD Metanalysis, 8964 pax ROBUST, 2652 pax 100% 80% 86% 91% 74% 87% 89% 60% 40% 20% 0% Sensitivity Specificity Normalcy

Detection of CAD 100% 80% 68 81 92 89 87 77 87 84 90 89 60% 40% 20% 0% Sensitivity Ex ECG (150 studies) Thallium SPECT (6 studies) Tetrofosmin SPECT Specificity Stress echo (14 studies) MIBI SPECT(3 studies) Adapted from Beller GA

Post-test probability Bayes Theorem 100 80 ECG + ECG - MPI + MPI - 60 40 Sens Spec ECG 0.68 0.77 MPS 0.92 0.88 20 0 0 10 20 30 40 50 60 70 80 90 100 Pre-test probability

Special circumstances in MPS LBBB, bifascicular block, and paced rhythm adenosine chronic lung disease with pulmonary hypertension false defects with dobutamine early after percutaneous coronary intervention?false defects in first 2-6 weeks balanced three vessel disease very rare dilated cardiomyopathy reversible defects possible

Artefact low count attenuation diaphragm inferior breast motion reconstruction apical thinning cold inferior wall

low count upward creep breast motion breast diaphragm

Stress Rest Stress Rest Conventional, backprojection Attenuation and scatter correction, iterative reconstruction

Angina unlikely Presentation with chest pain Assess nature of symptom risk factors examination Angina likely Avoid unnecessary tests Manage risk For definitive exclusion of CHD, consider MPI Yes Primary Able to exercise? Normal resting ECG? Male? Secondary Investigate & treat No High risk Exercise ECG Angiography Myocardial perfusion imaging Low risk Medical therapy Investigation of stable angina. BCS & RCP Guidelines. Heart 1999; 81: 546-55

ACC Guidelines, stable angina Ignoring guidelines CAG MPI ECG MPI CAG MPI CAG Gibbons RJ, et al. JACC 1999; 33: 2092-197

Southampton Chest Pain Clinic 1522 patients referred Dec 97 to Apr 2000 (630/yr) clinical management decisions by SpR with consultant supervision Male % Female % Ex-ECG 100 100 MPI 8 5 Angiogram 31 23 Normal angiogram 16 56 Wong Y et al. Heart 2001; 85: 149-152

Chest pain of recent onset Assessment and investigation of recent onset chest pain or discomfort of suspected cardiac origin NICE guidance March 2010 http://www.nice.org.uk/cg95

Contents Acute chest pain 215 pages 88 references 51 recommendations Stable chest pain 197 pages 60 references 42 recommendations http://www.nice.org.uk/cg95

Diagnosis of angina Clinical assessment alone Clinical assessment with obstructive CAD on anatomical testing Clinical assessment with myocardial ischaemia on functional testing

Features of angina 1. Constricting discomfort in the chest, neck, shoulders, jaw or arms 2. Precipitated by physical exertion or psychological stress 3. Relieved by rest of GTN within 5 minutes Three features = typical angina Two features = atypical angina One feature = non-anginal chest pain

Presentation with stable chest pain

Assessing likelihood of CAD Gibbons RJ, et al. ACC/AHA guideline for chronic stable angina 2002

Investigation of stable chest pain

Low pre-test likelihood If revascularisation not considered, or If invasive angiography is not appropriate or acceptable to the person Then, appropriate functional imaging Appropriate functional imaging

Moderate pre-test likelihood Use: MPS secho MR perfusion MR wall motion The choice of imaging method should take account of locally available technology and expertise, and the person and their preferences, including any contraindications

High pre-test likelihood If revascularisation not considered, or If invasive angiography is not appropriate or acceptable to the person Then, appropriate functional imaging

Established CAD Use: MPS secho MR perfusion MR wall motion The choice of imaging method should take account of locally available technology and expertise, and the person and their preferences, including any contraindications

Unhelpful investigations Do not use MR coronary angiography for diagnosis of CAD Do not use exercise ECG as the primary diagnostic test for ischaemia in people without known CAD

First line diagnostic investigations Likelihood <30% Coronary calcium imaging CTA if CAC 1-400 Functional imaging if CAC >400 Likelihood 30-60% Functional imaging Likelihood >60% ICA, if clinically appropriate and revasc considered Functional imaging, if ICA not appropriate

Total costs (CAD absent) 1600 P < 0.0001 Management 1400 Diagnosis 1200 1000 800 P < 0.05 P < 0.001 600 400 200 0 Strategy 1 2 3 4 Scint Non-scint EMPIRE study. Eur Heart J 1999; 20: 157-66

Angiography Rates N diagnostic % Normal N patients % mgmnt angios angiograms revascularised revascularised MPS users 43 28% 18 58% Non-users 86 43% 21 43% EMPIRE study. Eur Heart J 1999; 20: 157-66

EMPIRE implications for Southampton Annual Ex-ECG MPI Angio So ton 630 44 170 EMPIRE 253 285 92 MPS user approach to investigation would save 65,000 per year for the same outcome

Cost effectiveness of MPS Where are the savings? patient without CAD discharged without angiography patient with CAD managed medically without angiography avoid morbidity of angiography revascularisation targeted more effectively at high risk patients with most to gain

Clinical Indications for Perfusion Imaging Diagnosis abnormal resting ECG unable to exercise female intermediate likelihood of CAD after ex-ecg Management confirmation of ischaemia prognosis culprit lesion viable and jeopardised myocardium hibernating myocardium